Alcoholic Hepatitis Treatment Market To Reach USD 4.9 Billion By 2032 | DataHorizzon Research

The alcoholic hepatitis treatment market size was valued at USD 2.7 Billion in 2023 and is expected to reach a market size of USD 4.9 Billion by 2032 at a CAGR of 6.7%.

Fort Collins, Colorado, May 09, 2024 (GLOBE NEWSWIRE) —

The growing prevalence of alcohol-related liver diseases drives the demand for alcoholic hepatitis treatment in the forecast period.

The alcoholic hepatitis treatment market is witnessing significant growth, driven by the increasing prevalence of alcohol-related liver diseases globally. According to the World Health Organization (WHO), alcohol consumption contributes to over 3 million deaths annually, with a considerable portion attributed to alcoholic hepatitis. Additionally, heightened awareness about the severity of alcoholic hepatitis and the importance of early intervention has spurred a greater demand for effective treatments. Governments and healthcare organizations are intensifying efforts to educate the public about the risks associated with excessive alcohol consumption, further propelling market growth. For instance, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in the United States has launched several campaigns to raise awareness about alcohol-related liver diseases.

The Alcoholic Hepatitis Treatment market is also benefiting from advancements in diagnostic technologies and the emergence of novel treatment options. The introduction of non-invasive diagnostic tools, such as biomarkers and imaging techniques, has facilitated early detection and precise staging of alcoholic hepatitis. Furthermore, pharmaceutical companies are channeling substantial investments into research and development to identify new therapeutic targets and develop innovative medications. For example, the drug “Sulfasalazine” has demonstrated promising results in clinical trials for treating severe alcoholic hepatitis, as reported by a study published in the Journal of Hepatology. These advancements are poised to drive the growth of the alcoholic hepatitis treatment market in the foreseeable future.

Request Sample Report: 

https://bit.ly/4ds3a9D

Segmentation Overview:

The alcoholic hepatitis treatment market has been segmented into drug class, application, distribution channel, and region.

The hospital pharmacies accounted for a significant market share in 2023

  • Based on the market segmentation by distribution channel, the hospital pharmacies held the largest market share in 2023. Alcoholic hepatitis is a severe condition that often requires hospitalization and close monitoring by healthcare professionals.

The corticosteroids registered a significant share in 2023

  • Based on the market segmentation by drug class for the alcoholic hepatitis treatment market, the corticosteroids held the largest market share in 2023. Corticosteroids, such as prednisolone and methylprednisolone, have been the standard of care for treating severe alcoholic hepatitis for several decades. 

Ask For Discount 

https://bit.ly/3Wy5Xs6

Alcoholic Hepatitis Treatment Market Report Highlights:

  • The alcoholic hepatitis treatment market growth is anticipated at a CAGR of 6.7% by 2032.
  • North America, particularly the United States, currently holds the largest share in the alcoholic hepatitis treatment market.
  • The Asia-Pacific regional market is projected to witness the fastest growth in the Alcoholic Hepatitis Treatment market in the near future. The rapid economic development, increasing disposable incomes, and changing lifestyles have led to a rise in alcohol consumption in countries like China and India.
  • Some prominent players in the alcoholic hepatitis treatment market report include Gilead Sciences, Inc., AbbVie Inc., Sanofi, Novartis AG, Pfizer Inc., Merck & Co., Inc., Johnson & Johnson, Roche Holding AG, Bristol-Myers Squibb Company, Bayer AG, Eli Lilly and Company, and GlaxoSmithKline plc. 

Looking Exclusively For Region/Country Specific Report? 

https://bit.ly/3QCGNol

About DataHorizzon Research:

DataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. Its offerings include consulting services across enterprises and business insights to make actionable decisions. DHR’s comprehensive research methodology for predicting long-term and sustainable trends in the market facilitates complex decisions for organizations.

Contact:

Mail: sales@datahorizzonresearch.com

Ph: +1-970-672-0390

Website: https://datahorizzonresearch.com/

Follow Us: LinkedIn 

 

Recent Publications

Infectious Disease Therapeutics Market 2024 to 2032

Pain Management Devices Market 2024 to 2032

Injectable Drug Delivery Market 2024 to 2032

Anti Aging Market 2024 to 2032

Drug Discovery Services Market 2024 to 2032

CONTACT: Mail: sales@datahorizzonresearch.com Ph: +1-970-672-0390 Website: https://www.datahorizzonresearch.com 

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy